Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Dbv Technologies ADR (DBVT)
Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,077
  • Shares Outstanding, K 192,864
  • Annual Sales, $ 4,840 K
  • Annual Income, $ -96,270 K
  • 60-Month Beta 0.76
  • Price/Sales 28.89
  • Price/Cash Flow N/A
  • Price/Book 1.10
Trade DBVT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings $-0.09 on 10/31/23
  • Latest Earnings Date 03/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 42.79%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +30.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7650 +8.50%
on 02/20/24
0.9444 -12.11%
on 02/02/24
-0.0600 (-6.74%)
since 02/01/24
3-Month
0.6675 +24.34%
on 12/04/23
1.0700 -22.43%
on 12/27/23
+0.0870 (+11.71%)
since 12/01/23
52-Week
0.6500 +27.69%
on 11/27/23
2.3700 -64.98%
on 05/15/23
-0.6200 (-42.76%)
since 03/01/23

Most Recent Stories

More News
Why Shares of DBV Technologies Jumped Thursday

The New England Journal of Medicine reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers.

DBVT : 0.8300 (+1.22%)
BeiGene, Ltd. (BGNE) Surges 12.5%: Is This an Indication of Further Gains?

BeiGene, Ltd. (BGNE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

BGNE : 165.02 (-0.38%)
DBVT : 0.8300 (+1.22%)
DBV (DBVT) Up as FDA Lifts Partial Hold on Peanut Allergy Study

The FDA lifts the partial clinical hold on DBV Technologies' (DVBT) phase III VITESSE study of a modified Viaskin Peanut patch in peanut-allergic children aged four to seven years. Stock rises.

ADAP : 1.5900 (+1.27%)
DBVT : 0.8300 (+1.22%)
ASLN : 0.7142 (-18.84%)
IMCR : 67.41 (+0.28%)
Why DBV Technologies Stock Is Soaring Today

The company can now move forward with a late-stage study of its lead pipeline candidate.

DBVT : 0.8300 (+1.22%)
Pre-Market Brief: Stocks Mixed As Strong Economic Data Fuel Rate Hike Worries

March S&P 500 futures (ESH23) are trending up +0.17% this morning after three major U.S. benchmark indices closed sharply lower on Thursday, with the technology-heavy Nasdaq dropping the most after stronger-than-expected...

ESH23 : 3,957.05s (-0.09%)
XPON : 3.86 (-5.05%)
TSLA : 202.64 (+0.38%)
AMC : 4.36 (+0.93%)
BTBT : 2.71 (+4.23%)
DBVT : 0.8300 (+1.22%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DBV Technologies S.A. (""DBV" or the "Company") (NASDAQ: DBVT). Such investors...

DBVT : 0.8300 (+1.22%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DBV Technologies S.A. (""DBV" or the "Company") (NASDAQ: DBVT). Such investors...

DBVT : 0.8300 (+1.22%)
DBV Technologies' (DBVT) Peanut Allergy Study on Partial Hold

DBV Technologies (DVBT) announces partial hold on phase III study of modified Viaskin Peanut 250 ??g patch, VITESSE, by the FDA. Stock declines.

STSA : 1.1000 (-0.90%)
DBVT : 0.8300 (+1.22%)
ARDS : 0.0740 (-4.15%)
IMCR : 67.41 (+0.28%)
DBV Technologies Reports Second Quarter 2022 Financial Results

Montrouge, France, August 1, 2022 DBV Technologies Reports Second Quarter 2022 Financial Results DBV closes Q2 with a cash balance of $248M following...

DBVT : 0.8300 (+1.22%)
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATIONMontrouge, France, July 27, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies...

DBVT : 0.8300 (+1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting...

See More

Key Turning Points

3rd Resistance Point 0.8900
2nd Resistance Point 0.8600
1st Resistance Point 0.8450
Last Price 0.8300
1st Support Level 0.8000
2nd Support Level 0.7700
3rd Support Level 0.7550

See More

52-Week High 2.3700
Fibonacci 61.8% 1.7130
Fibonacci 50% 1.5100
Fibonacci 38.2% 1.3070
Last Price 0.8300
52-Week Low 0.6500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar